3rd Synthetic Biology Based Therapeutics Summit

Advancing Gene Editing, AI and Logic Gating to Develop Safe, Controllable Cell and Gene, mRNA and Microbiome-based Therapies

Time: 9:00 AM – 5:15 PM

Venue Details: Boston Park Plaza, 50 Park Plaza, Boston, Massachusetts, 02116, United States

Prices:
Industry | Conference + Workshop Day: USD 3597.00,
Industry | Conference Only: USD 2599.00,
Academic | Conference + Workshop Day: USD 3097.00,
Academic | Conference Only: USD 2199.00,
Vendor | Conference + Workshop Day: USD 5297.00,
Vendor | Conference Only: USD 3799.00

Speakers: Anders Lund | Director, Analytical Development | Synlogic, Brian Garrison | Senior Director of Research | Senti Biosciences Inc., Casey Lippmeier | Senior Vice President, Innovation | Conagen Inc, Christopher Raggio | Angel Investor | Raggio Capital, Gregory Linshiz | Associate Director – Synthetic Biology | Replay, Jamie Spangler | Assistant Professor, Biomedical Chemical and Biomolecular Engineering | Johns Hopkins, Jason Kelly | Founder and Chief Executive Officer | Ginkgo Bioworks Inc., Jaspreet Khurana | Director, Platform and Discovery | Strand Therapeutics Inc., Jodi Barrientos | Chief Business Officer | Ribbon Biolabs, and more